Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling.
暂无分享,去创建一个
Joaquim M S Cabral | Tiago G Fernandes | Cláudia C Miranda | M Margarida Diogo | J. Cabral | T. Fernandes | M. M. Diogo | Cláudia C. Miranda
[1] George Church,et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.
[2] Robert Zweigerdt,et al. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.
[3] Martin J. Aryee,et al. Epigenetic memory in induced pluripotent stem cells , 2010, Nature.
[4] Robert H. Brown,et al. Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.
[5] Takanori Takebe,et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.
[6] Tiago G Fernandes,et al. Towards Multi-Organoid Systems for Drug Screening Applications , 2018, Bioengineering.
[7] M. Suematsu,et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.
[8] P. Garcez,et al. Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.
[9] Oswald Steward,et al. Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.
[10] Alex A. Pollen,et al. Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia. , 2017, Cell stem cell.
[11] Tiago G Fernandes,et al. Neural commitment of human pluripotent stem cells under defined conditions recapitulates neural development and generates patient-specific neural cells. , 2015, Biotechnology journal.
[12] S. Haupt,et al. A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension. , 2015, Biotechnology journal.
[13] E. Sasaki,et al. Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.
[14] Hideshi Kawakami,et al. Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. , 2015, Cell reports.
[15] D. Surmeier,et al. Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.
[16] Robert Zweigerdt,et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. , 2010, Stem cell research.
[17] Ali Khademhosseini,et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform , 2017, Scientific Reports.
[18] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[19] Shuying Yang,et al. Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.
[20] Tara Srinivasan,et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing , 2017, Nature Medicine.
[21] Mike J. Mason,et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.
[22] C Maayan,et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. , 2001, American journal of human genetics.
[23] John B. Furness,et al. The enteric nervous system and neurogastroenterology , 2012, Nature Reviews Gastroenterology &Hepatology.
[24] T. Crawford,et al. The Neurobiology of Childhood Spinal Muscular Atrophy , 1996, Neurobiology of Disease.
[25] N. Nakatsuji,et al. A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production , 2014, Stem cell reports.
[26] I. Wilmut,et al. Sheep cloned by nuclear transfer from a cultured cell line , 1996, Nature.
[27] Marius Wernig,et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.
[28] F. Ginhoux,et al. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells , 2017, Stem cell reports.
[29] Yoshiki Sasai,et al. Fluorescence‐Activated Cell Sorting–Based Purification of Embryonic Stem Cell–Derived Neural Precursors Averts Tumor Formation after Transplantation , 2006, Stem cells.
[30] Z. Warren,et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. , 2014, Morbidity and mortality weekly report. Surveillance summaries.
[31] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[32] Hynek Wichterle,et al. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.
[33] Thomas Scheper,et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. , 2010, Stem cell research.
[34] P. Gutin,et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. , 2015, Cell stem cell.
[35] Peter W Zandstra,et al. Niche‐mediated control of human embryonic stem cell self‐renewal and differentiation , 2007, The EMBO journal.
[36] Xin Li,et al. A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.
[37] Amy Cochrane,et al. Direct reprogramming of adult cells: avoiding the pluripotent state , 2014 .
[38] Eugenia Kumacheva,et al. Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.
[39] Alan Trounson,et al. Stem Cell Therapies in Clinical Trials: Progress and Challenges. , 2015, Cell stem cell.
[40] J. Itskovitz‐Eldor,et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells , 2011, Nature Protocols.
[41] Allan J. Robins,et al. A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells , 2012, PloS one.
[42] Maria Margarida Diogo,et al. Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers. , 2015, Methods in molecular biology.
[43] E. RancourtDerrick,et al. Factorial Experimental Design for the Culture of Human Embryonic Stem Cells as Aggregates in Stirred Suspension Bioreactors Reveals the Potential for Interaction Effects Between Bioprocess Parameters , 2014 .
[44] Xiaofang Sun,et al. Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3′,5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes , 2017, Front. Endocrinol..
[45] H. Honda,et al. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine , 2018, Scientific Reports.
[46] Joaquim M S Cabral,et al. Dissolvable Microcarriers Allow Scalable Expansion And Harvesting Of Human Induced Pluripotent Stem Cells Under Xeno-Free Conditions. , 2018, Biotechnology journal.
[47] Gordana Vunjak-Novakovic,et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells , 2018, Nature.
[48] Takashi Daimon,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.
[49] A. Viale,et al. Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.
[50] Tiago G Fernandes,et al. Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems , 2016, PloS one.
[51] Jacob W. Guggenheim,et al. A process engineering approach to increase organoid yield , 2017, Development.
[52] Sean P. Palecek,et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.
[53] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[54] Karl-Ludwig Laugwitz,et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.
[55] H. Young,et al. Hirschsprung disease: a developmental disorder of the enteric nervous system , 2013, Wiley interdisciplinary reviews. Developmental biology.
[56] T. Kanazu,et al. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine , 2018, Drug Metabolism and Disposition.
[57] T. Adachi,et al. Self-organizing optic-cup morphogenesis in three-dimensional culture , 2011, Nature.
[58] Alain Bel,et al. Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. , 2018, Journal of the American College of Cardiology.
[59] Tiago G Fernandes,et al. Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture , 2019, Scientific Reports.
[60] S. Yamanaka,et al. Induction of pluripotency by defined factors. , 2010, Experimental cell research.
[61] E. Wirth,et al. Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. , 2015, Regenerative medicine.
[62] Fengtang Yang,et al. Human blood vessel organoids as a model of diabetic vasculopathy , 2019, Nature.
[63] Fred H. Gage,et al. A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.
[64] J. Bagley,et al. Fused cerebral organoids model interactions between brain regions , 2017, Nature Methods.
[65] Hossein Baharvand,et al. Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. , 2011, Stem cells and development.
[66] Yasuko Matsumura,et al. A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.
[67] M. S. Kallos,et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. , 2010, Tissue engineering. Part C, Methods.
[68] L. Ye,et al. Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling , 2013, Circulation.
[69] Philippe Aubert,et al. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system , 2016, Nature Medicine.
[70] Jiannis Ragoussis,et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels , 2012, Proceedings of the National Academy of Sciences.
[71] Gail H Deutsch,et al. In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.
[72] Joaquim M. S. Cabral,et al. Scalable culture of human induced pluripotent cells on microcarriers under xeno-free conditions using single-use vertical-wheel™ bioreactors , 2018, Journal of Chemical Technology & Biotechnology.
[73] A. Björklund,et al. Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease , 2014, Cell stem cell.
[74] E. Wirth,et al. Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury , 2017, Stem cells translational medicine.
[75] T. Fernandes,et al. Scaling up a chemically‐defined aggregate‐based suspension culture system for neural commitment of human pluripotent stem cells , 2016, Biotechnology journal.
[76] S. Schwartz,et al. Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.
[77] G. Bett,et al. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy , 2015, Disease Models & Mechanisms.
[78] V. Vedantham,et al. Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.
[79] Tiago G Fernandes,et al. A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies. , 2018, Toxicology letters.
[80] Kevin Eggan,et al. Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells , 2005, Science.
[81] Robert Zweigerdt,et al. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture , 2015, Nature Protocols.
[82] P. Zandstra,et al. Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates , 2008, PloS one.
[83] Hideyuki Okano,et al. Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity , 2012, PloS one.
[84] D. Cyranoski. ‘Reprogrammed’ stem cells to treat spinal-cord injuries for the first time , 2019, Nature.
[85] T. Ichisaka,et al. Generation of germline-competent induced pluripotent stem cells , 2007, Nature.
[86] M. Moorman,et al. Insulin‐Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo , 2015, Stem cells translational medicine.
[87] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[88] R. Schwartz,et al. Scalable Production and Cryostorage of Organoids Using Core–Shell Decoupled Hydrogel Capsules , 2017, Advanced biosystems.
[89] D. Melton,et al. Nuclear Reprogramming in Cells , 2008, Science.
[90] Maria Margarida Diogo,et al. Separation technologies for stem cell bioprocessing , 2012, Biotechnology and bioengineering.
[91] S. Lopes,et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.
[92] N. Benvenisty,et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.
[93] Cindy Hamil,et al. Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.
[94] H. Onoe,et al. MHC matching improves engraftment of iPSC-derived neurons in non-human primates , 2017, Nature Communications.
[95] Gang Bao,et al. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection , 2014, Proceedings of the National Academy of Sciences.
[96] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[97] P. Burridge,et al. Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V‐96 Plate Aggregation System Highlights Interline Variability , 2007, Stem cells.
[98] Tiago G. Fernandes,et al. Spatial and temporal control of cell aggregation efficiently directs human pluripotent stem cells towards neural commitment. , 2015, Biotechnology journal.
[99] J. Cabral,et al. Long‐term expansion of human induced pluripotent stem cells in a microcarrier‐based dynamic system , 2017 .
[100] M. Sittinger,et al. Effect of inoculum density on human‐induced pluripotent stem cell expansion in 3D bioreactors , 2019, Cell proliferation.
[101] Jeffrey M Karp,et al. Engineering Stem Cell Organoids. , 2016, Cell stem cell.
[102] Praveen Shukla,et al. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. , 2015, Stem cell research.
[103] H. Schöler,et al. Induced pluripotent stem cells at nanoscale. , 2010, Stem cells and development.
[104] T. Nielsen,et al. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1. , 2016, Stem cell research.
[105] Cátia Bandeiras,et al. Bringing stem cell-based therapies for type 1 diabetes to the clinic: early insights from bioprocess economics and cost-effectiveness analysis. , 2019, Biotechnology journal.
[106] Pablo Menendez,et al. Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection , 2010, Stem cells.
[107] James A. Thomson,et al. Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.
[108] Hossein Baharvand,et al. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells , 2015, Stem cells translational medicine.
[109] R. Kamm,et al. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons , 2018, Science Advances.
[110] Hong Wang,et al. Naïve Induced Pluripotent Stem Cells Generated From β‐Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9 , 2016, Stem cells translational medicine.
[111] A. Trounson,et al. Cell fusion for reprogramming pluripotency , 2007, Stem Cell Reviews.
[112] S. Gerecht,et al. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. , 2013, Stem cell research.
[113] Donghui Jing,et al. Cardiac Cell Generation from Encapsulated Embryonic Stem Cells in Static and Scalable Culture Systems , 2010, Cell transplantation.
[114] Juergen A. Knoblich,et al. Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.
[115] H. Okochi,et al. Induction of functional islet-like cells from human iPS cells by suspension culture , 2019, Regenerative therapy.
[116] Nuala Trainor,et al. Rethinking clinical delivery of adult stem cell therapies , 2014, Nature Biotechnology.
[117] Satoshi Morita,et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model , 2017, Nature.
[118] H. Baharvand,et al. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. , 2012, Tissue engineering. Part C, Methods.
[119] M. Ohkura,et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.
[120] H. Clevers,et al. Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels , 2017, Development.
[121] Robert Zweigerdt,et al. Scalable expansion of human pluripotent stem cells in suspension culture , 2011, Nature Protocols.
[122] Rudolf Jaenisch,et al. Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.
[123] M. Gerstein,et al. FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.
[124] D. Kaufman,et al. Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation , 2006, Biotechnology and bioengineering.
[125] Vincent C. Chen,et al. Scalable GMP compliant suspension culture system for human ES cells. , 2012, Stem cell research.
[126] P. Sullivan,et al. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.
[127] Robert Lanza,et al. EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .
[128] F. Yi,et al. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs , 2017, Protein & Cell.
[129] O. Klein,et al. Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo , 2015, Stem cell reports.
[130] E. Kroon,et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.
[131] J. Itskovitz‐Eldor,et al. Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.
[132] M. Fussenegger,et al. The Growth Factor Inhibitor Suramin Reduces Apoptosis and Cell Aggregation in Protein‐Free CHO Cell Batch Cultures , 2000, Biotechnology progress.
[133] T. McDevitt,et al. Rotary Suspension Culture Enhances the Efficiency, Yield, and Homogeneity of Embryoid Body Differentiation , 2007, Stem cells.
[134] Robert Zweigerdt,et al. Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.
[135] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[136] Chad A. Cowan,et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. , 2010, The Journal of clinical investigation.
[137] A. Bradley,et al. Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements , 2018, Nature Biotechnology.
[138] Robert Zweigerdt,et al. Large scale production of stem cells and their derivatives. , 2009, Advances in biochemical engineering/biotechnology.
[139] Thomas Vierbuchen,et al. Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.
[140] Qisheng Zhang,et al. High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain. , 2017, Cell stem cell.
[141] Madeline A. Lancaster,et al. Cerebral organoids model human brain development and microcephaly , 2013, Nature.
[142] Tiago G Fernandes,et al. Clinical‐scale purification of pluripotent stem cell derivatives for cell‐based therapies , 2015, Biotechnology journal.
[143] Todd C McDevitt,et al. The multiparametric effects of hydrodynamic environments on stem cell culture. , 2011, Tissue engineering. Part B, Reviews.
[144] Alain Bel,et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. , 2015, European heart journal.
[145] Robert Zweigerdt,et al. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single‐Use Stirred Tank Bioreactors , 2016, Stem cells translational medicine.
[146] Fred H. Gage,et al. Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.
[147] A. Gentles,et al. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. , 2017, Cell stem cell.
[148] P. Itsykson,et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension , 2010, Nature Biotechnology.
[149] T. Karlsen,et al. Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.
[150] Martin Fussenegger,et al. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. , 2003, Biotechnology and bioengineering.
[151] G. Warnock,et al. Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice , 2012, Diabetes.
[152] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[153] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[154] Peter W Zandstra,et al. Chemically controlled aggregation of pluripotent stem cells , 2018, Biotechnology and bioengineering.
[155] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[156] D. Kotton,et al. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. , 2017, Cell stem cell.
[157] Z. Ou,et al. Microdeletions including YWHAE in the Miller–Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment , 2009, Journal of Medical Genetics.
[158] Shuichi Takayama,et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.
[159] F. Leisch,et al. Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting , 2018, Biotechnology and bioengineering.
[160] J. Thomson,et al. Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.
[161] I. Saitoh,et al. Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection , 2014, Cell Death and Differentiation.
[162] J V Castell,et al. Human hepatocytes as a tool for studying toxicity and drug metabolism. , 2003, Current drug metabolism.